Skip to main content
. 2020 Jul 9;51(4):1553–1561. doi: 10.1007/s42770-020-00336-8

Table 2.

Plasmids used in this study

Plasmids Description Source
pSN40 C. maltosa LEU2 (CmLEU2), KanaR in the pCR-BluntII TOPO [14]
pSN52 C. dubliniensis HIS1 (CdHIS1), KanaR in the pCR-BluntII TOPO [14]
pCPC20 C. albicans vector containing ADH1 promoter and Loxp-CdARG4-Loxp (PAP) maker for integration at ADE2 locus [14]
pJY1 2.95-kb C. albicans wild-type TAC1 from ADH1 promoter in pCPC20 This study
pJY2 2.95-kb TAC1 of C. albicans clinical isolate C16 from ADH1 promoter in pCPC20 This study
pJY3 2.95-kb TAC1 of C. albicans clinical isolate C13 from ADH1 promoter in pCPC20 This study
pJY11 TAC1S264P derived from pJY1 This study
pJY12 TAC1A736V derived from pJY1 This study
pJY13 TAC1V736A derived from pJY2 This study
pJY14 TAC1H741D derived from pJY1 This study
pJY15 TAC1D741H derived from pJY3 This study